Vera Therapeutics, Inc. (VERA) Earnings
Vera Therapeutics, Inc. is expected to report next earnings on November 4, 2026 (in NaN days), with a consensus EPS estimate of $-1.61. VERA has beaten EPS estimates in 4 of its last 12 reported quarters (average surprise -3.8% over the last four).
Next earnings
Nov 4, 2026in NaN days
EPS est $-1.61 · Revenue est $4M
Track record
Beat EPS in 4 of 12 quarters
Avg surprise -3.8% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 10, 2026 | $-1.58 | $-1.52 | +3.8% | — | — |
| May 7, 2026 | $-1.33 | $-1.69 | -27.2% | — | — |
| Nov 5, 2025 | $-1.20 | $-1.26 | -5.0% | — | — |
| Feb 26, 2025 | $-0.83 | $-0.72 | +13.3% | — | — |
| Nov 7, 2024 | $-0.69 | $-0.85 | -23.2% | — | — |
| Aug 8, 2024 | $-0.58 | $-0.62 | -6.9% | — | — |
| May 9, 2024 | $-0.53 | $-0.56 | -5.7% | — | — |
| Mar 20, 2024 | $-0.53 | $-0.58 | -9.4% | — | — |
| Nov 9, 2023 | $-0.50 | $-0.45 | +10.0% | — | — |
| Aug 10, 2023 | $-0.69 | $-0.46 | +33.3% | — | — |
| May 11, 2023 | $-0.60 | $-0.80 | -33.3% | — | — |
| Nov 9, 2022 | $-0.72 | $-0.91 | -26.4% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.